150 Recruiting Trials

Clinical Trials for Multiple Sclerosis

MS trials investigate disease-modifying therapies, remyelination strategies, stem-cell transplants, and neuroprotective agents for relapsing and progressive forms of MS.

Showing 15 of 150 recruiting trials

Non-inferiority Study of Frexalimab Subcutaneous Administration Compared to Intravenous Administration in Adult Participants With Multiple Sclerosis
PHASE3 Cullman, Alabama +4 more NCT07325292
Recruiting
Dalfampridine Combined With Physical Therapy for Mobility Impairment in Multiple Sclerosis
PHASE3 Boston, Massachusetts NCT06136728
Recruiting
Effect of Corticosteroids on Inflammation at the Edge of Acute Multiple Sclerosis Plaques
PHASE2 Bethesda, Maryland NCT02784210
Recruiting
Targeting Residual Activity By Precision, Biomarker-Guided Combination Therapies of Multiple Sclerosis (TRAP-MS)
PHASE1 Bethesda, Maryland NCT03109288
Recruiting
Mechanisms of Cannabidiol in Persons With MS: the Role of Sleep and Pain Phenotype
PHASE2 Ann Arbor, Michigan NCT05269628
Recruiting
Targeting Agonists of Glucagon-like Peptide-1 Receptor for Multiple Sclerosis
PHASE2 Baltimore, Maryland +1 more NCT07497399
Recruiting
Home-Based Transcranial Direct Current Stimulation (tDCS) for Depression in Multiple Sclerosis (MS)
PHASE2 New York, New York NCT06901687
Recruiting
A Study to Investigate Multiple Sclerosis Relapse Prevention With mRNA-1195 Compared With Placebo in Participants Aged 18 to ≤55 Years
PHASE2 Boston, Massachusetts +4 more NCT06735248
Recruiting
Efficacy of Cognitive Behavioral Therapy for Insomnia to Treat Insomnia Symptoms in Individuals With Multiple Sclerosis
PHASE2 Kansas City, Kansas NCT06428006
Recruiting
Solriamfetol for the Treatment of Multiple Sclerosis Fatigue
PHASE2 Baltimore, Maryland NCT06170970
Recruiting
Hyperpolarized Carbon Metabolic Imaging in Multiple Sclerosis
PHASE2 San Francisco, California NCT07510607
Recruiting
Treatment of Participants With Primary or Secondary Progressive Multiple Sclerosis
PHASE1 Kansas City, Kansas +1 more NCT07477639
Recruiting
Molecular Imaging of NET Using [C-11]MRB-PET in MS
PHASE1 Boston, Massachusetts NCT03207464
Recruiting
PET Brain Imaging in Multiple Sclerosis, Alzheimer's Disease, and Other Neurological and Neuropsychiatric Diseases
PHASE1 Boston, Massachusetts NCT02649985
Recruiting
Metformin as an add-on or Monotherapy in Treatment of Aging People With Multiple Sclerosis (MS)
PHASE2 Buffalo, New York NCT06463743
Recruiting
See all 150 results
Helpful Reading
Are Clinical Trials Safe? What Patients Should Know
How clinical trial safety works — phases, IRB oversight, informed consent, and your right to withdraw — plus the real risks and questions to ask.
How to Know If You Qualify for a Clinical Trial
Every trial has eligibility criteria based on diagnosis, age, and medical history. Here's how to tell if you qualify — and what to do if you're not sure.
Clinical Trials Without Insurance: What You Need to Know
Clinical trials cover the cost of study-related care, making them one of the few ways to access treatment without health insurance. Here's what's covered.
All guides →

Check Your Eligibility

Create a free profile and our AI will match you to trials you may qualify for.

Get Matched — Free
No insurance required
Browse by Condition
Diabetes Cancer Breast Cancer Depression Anxiety Alzheimer's Heart Disease Asthma Multiple Sclerosis Obesity Parkinson's Lupus Hypertension COPD Stroke Arthritis Kidney Disease COVID-19
Multiple Sclerosis Trials by State
California Texas New York Florida Illinois Pennsylvania Ohio Georgia North Carolina Michigan New Jersey Washington Arizona Massachusetts Tennessee Colorado Minnesota Maryland Wisconsin Oregon